Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma
NCT02345408
Interventional
Phase 1
Completed
This is an open-label phase 1-b study to evaluate the safety and efficacy of CCX872-B in patients with pancreatic adenocarcinoma also receiving FOLFIRINOX chemotherapy.
Feb 28,2015
All
18 Years
N/A
18 Years
N/A
54